- Corporate Officers - C
- Cormorant Private Healthcare Fund Ii, Lp
Insider Trading History of Cormorant Private Healthcare Fund Ii, Lp
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cormorant Private Healthcare Fund Ii, Lp since 2020.
This trader's CIK number is 1747677.
At the time of last reporting, Cormorant Private Healthcare Fund Ii, Lp was the Officer of Erasca, Inc.. (stock ticker symbol ERAS).
Also see all insider trading activities at Erasca, Inc..
Note that in the past
Cormorant Private Healthcare Fund II, LP also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akouos, Inc. (AKUS) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKUS | 290,000 | $4,930,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Erasca, Inc. (ERAS) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ERAS | 307,692 | $1,999,998 | 0 | $0 | 0 | $0 |
| 2021 | ERAS | 950,000 | $15,200,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Avidity Biosciences, Inc. (RNA) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | RNA | 300,000 | $5,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Rain Therapeutics Inc. (RAIN) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RAIN | 450,000 | $7,650,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Monte Rosa Therapeutics, Inc. (GLUE) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | GLUE | 600,000 | $11,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bioatla, Inc. (BCAB) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BCAB | 800,000 | $14,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aerovate Therapeutics, Inc. (AVTE) by Cormorant Private Healthcare Fund Ii, Lp
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | AVTE | 500,000 | $7,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Cormorant Private Healthcare Fund Ii, Lp:
1. Akouos, Inc. (AKUS)
2. Erasca, Inc. (ERAS)
3. Avidity Biosciences, Inc. (RNA)
4. Rain Therapeutics Inc. (RAIN)
5. Monte Rosa Therapeutics, Inc. (GLUE)
6. Bioatla, Inc. (BCAB)
7. Aerovate Therapeutics, Inc. (AVTE)
Table 1. Insider trading of Akouos, Inc. (AKUS) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-30 | AKUS | Buy | 290,000 | 17.00 | 4,930,000 |
Table 2. Insider trading of Erasca, Inc. (ERAS) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-12-13 | ERAS | Buy | 307,692 | 6.50 | 1,999,998 |
| 2021-07-20 | ERAS | Buy | 950,000 | 16.00 | 15,200,000 |
Table 3. Insider trading of Avidity Biosciences, Inc. (RNA) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-16 | RNA | Buy | 300,000 | 18.00 | 5,400,000 |
Table 4. Insider trading of Rain Therapeutics Inc. (RAIN) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-04-27 | RAIN | Buy | 450,000 | 17.00 | 7,650,000 |
Table 5. Insider trading of Monte Rosa Therapeutics, Inc. (GLUE) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-28 | GLUE | Buy | 600,000 | 19.00 | 11,400,000 |
Table 6. Insider trading of Bioatla, Inc. (BCAB) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-18 | BCAB | Buy | 800,000 | 18.00 | 14,400,000 |
Table 7. Insider trading of Aerovate Therapeutics, Inc. (AVTE) by Cormorant Private Healthcare Fund Ii, Lp
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-07-02 | AVTE | Buy | 500,000 | 14.00 | 7,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Cormorant Private Healthcare Fund Ii, Lp
(Officer of Erasca, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.